首页|化痰通络汤联合常规西药治疗急性脑梗死患者的效果

化痰通络汤联合常规西药治疗急性脑梗死患者的效果

扫码查看
目的:观察化痰通络汤联合常规西药治疗急性脑梗死(ACI)患者的效果.方法:选取 2021 年 3 月至 2023 年 3 月临颍县中医院收治的 76 例ACI患者进行前瞻性研究,按照随机数字表法将其分为观察组和对照组各 38 例.两组均予以常规治疗,在此基础上,对照组予以常规西药(阿司匹林+阿托伐他汀钙)治疗,观察组在对照组基础上联合化痰通络汤治疗.比较两组临床疗效,治疗前后神经功能缺损[美国国立卫生研究院卒中量表(NIHSS)]评分、日常生活能力[Barthel指数(BI)]评分、血脂指标[总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)、三酰甘油(TG)]水平、炎性因子[超敏C反应蛋白(hs-CRP)、白细胞介素-6(IL-6)]水平,以及不良反应发生率.结果:观察组治疗总有效率为 92.11%(35/38),高于对照组的 73.68%(28/38),差异有统计学意义(P<0.05);治疗后,观察组NIHSS评分低于对照组,BI评分高于对照组,差异均有统计学意义(P<0.05);治疗后,观察组TC、LDL-C、TG、IL-6、hs-CRP水平均低于对照组,差异有统计学意义(P<0.05);两组不良反应发生率比较,差异无统计学意义(P>0.05).结论:化痰通络汤联合常规西药治疗ACI患者可提高治疗总有效率和日常生活能力评分,降低神经功能缺损评分和血脂指标、炎性因子水平,效果优于单纯常规西药治疗.
Effects of Huatan Tongluo decoction combined with conventional Western medicine on patients with acute cerebral infarction
Objective:To observe effects of Huatan Tongluo decoction combined with conventional Western medicine in treatment of patients with acute cerebral infarction(ACI).Methods:A prospective study was conducted on 76 patients with ACI admitted to Linying County Hospital of traditional Chinese Medicine from March 2021 to March 2023.According to the random number table method,they were divided into observation group and control group,38 cases in each group.Both groups were given routine treatment.On this basis,the control group was treated with conventional Western medicine(Aspirin+Atorvastatin calcium),while the observation group was treated with Huatan Tongluo decoction on the basis of that of the control group.The clinical efficacy,the neurological deficit[National Institutes of Health stroke scale(NIHSS)]score,the daily living ability[Barthel index(BI)]score,the blood lipid indexes[total cholesterol(TC),low-density lipoprotein cholesterol(LDL-C),triglyceride(TG)]levels,the inflammatory factors[high-sensitivity C-reactive protein(hs-CRP),interleukin-6(IL-6)]levels before and after the treatment,and the incidence of adverse reactions were compared between the two groups.Results:The total effective rate of the observation group was 92.11%(35/38),which was higher than 73.68%(28/38)of the control group,and the difference was statistically significant(P<0.05).After the treatment,the NIHSS score of the observation group was lower than that of the control group,the BI score was higher than that of the control group,and the differences were statistically significant(P<0.05).After the treatment,the levels of TC,LDL-C,TG,IL-6 and hs-CRP in the observation group were lower than those in the control group,and the differences were statistically significant(P<0.05).However,there was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusions:Huatan Tongluo decoction combined with conventional Western medicine can improve the total effective rate and the daily living ability scores of the ACI patients,and reduce the neurological deficit scores,the blood lipid indexes and inflammatory factor levels.Moreover,it is superior to simple conventional Western medicine treatment.

Acute cerebral infarctionHuatan Tongluo decoctionInflammatory factorDaily living abilityNeurological deficitBlood lipidAdverse reaction

李阳、王保申、付菊花

展开 >

临颍县中医院内二科(脑病科),河南 漯河 462600

漯河市中医院脑病二科,河南 漯河 462000

急性脑梗死 化痰通络汤 炎性因子 日常生活能力 神经功能缺损 血脂 不良反应

河南省中医药传承与创新人才工程(仲景工程)中医药青苗人才培养项目

豫卫中医函[2021]16号

2024

中国民康医学
中国社会工作协会

中国民康医学

影响因子:0.649
ISSN:1672-0369
年,卷(期):2024.36(19)
  • 11